Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment

1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment

US Patent 9227946 · Granted Jan 5, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-pro2025
Formulations/compositions comprising ibrutinib2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-prop2024
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
Vortioxetine pyroglutamate2022
Vortioxetine pyroglutamate2022
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-prop2021
Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperaz2020
Vortioxetine pyroglutamate2019
Vortioxetine pyroglutamate2019
Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropr2018